209 related articles for article (PubMed ID: 23669414)
1. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
[TBL] [Abstract][Full Text] [Related]
2. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.
Ho SB; Bräu N; Cheung R; Liu L; Sanchez C; Sklar M; Phelps TE; Marcus SG; Wasil MM; Tisi A; Huynh L; Robinson SK; Gifford AL; Asch SM; Groessl EJ
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):2005-14.e1-3. PubMed ID: 25724704
[TBL] [Abstract][Full Text] [Related]
3. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
6. Management of chronic hepatitis C in veterans: the potential of integrated care models.
Ho SB; Groessl E; Dollarhide A; Robinson S; Kravetz D; Dieperink E
Am J Gastroenterol; 2008 Jul; 103(7):1810-23. PubMed ID: 18564122
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis C self-management program: sustainability of primary outcomes at 1 year.
Groessl EJ; Ho SB; Asch SM; Stepnowsky CJ; Laurent D; Gifford AL
Health Educ Behav; 2013 Dec; 40(6):730-40. PubMed ID: 23445604
[TBL] [Abstract][Full Text] [Related]
8. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
[TBL] [Abstract][Full Text] [Related]
10. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of disease in U.S. veteran patients with hepatitis C.
Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
[TBL] [Abstract][Full Text] [Related]
12. Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.
Jerkeman A; Norkrans G; Lidman C; Westin J; Lagging M; Frimand J; Simonsberg C; Kakko J; Widell A; Björkman P
Eur J Gastroenterol Hepatol; 2014 May; 26(5):523-31. PubMed ID: 24637496
[TBL] [Abstract][Full Text] [Related]
13. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
Charlebois A; Lee L; Cooper E; Mason K; Powis J
J Viral Hepat; 2012 Dec; 19(12):836-42. PubMed ID: 23121361
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
[TBL] [Abstract][Full Text] [Related]
16. Initiation of Primary Care-Mental Health Integration programs in the VA Health System: associations with psychiatric diagnoses in primary care.
Zivin K; Pfeiffer PN; Szymanski BR; Valenstein M; Post EP; Miller EM; McCarthy JF
Med Care; 2010 Sep; 48(9):843-51. PubMed ID: 20706160
[TBL] [Abstract][Full Text] [Related]
17. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
Timko C; Dixon K; Moos RH
Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
[TBL] [Abstract][Full Text] [Related]
18. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
Belperio PS; Hwang EW; Thomas IC; Mole LA; Cheung RC; Backus LI
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1021-7. PubMed ID: 23524130
[TBL] [Abstract][Full Text] [Related]
19. A telehealth intervention for veterans on antiviral treatment for the hepatitis C virus.
Silberbogen AK; Ulloa E; Mori DL; Brown K
Psychol Serv; 2012 May; 9(2):163-73. PubMed ID: 22662730
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis C self-management programme: a randomized controlled trial.
Groessl EJ; Weingart KR; Stepnowsky CJ; Gifford AL; Asch SM; Ho SB
J Viral Hepat; 2011 May; 18(5):358-68. PubMed ID: 20529203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
